Per-Se Technologies, MediNotes Expand Relationship to Provide Total Practice Management and EMR Solution

Per-Se Technologies announced today an extension of its non-exclusive relationship with one of the leading providers of electronic medical record (EMR) systems, MediNotes Corporation. Together with Per-Se's practice management systems, the two companies will offer a fully integrated, best-of-breed information solution tailored for small physician practices across the country.

Per-Se will continue to offer its practice management solutions, Medisoft™ or Lytec®, together with MediNotes e EMR to deliver a comprehensive and cost-effective patient and office management suite. This alliance offers Lytec or Medisoft customers the option to fully integrate MediNotes e EMR with their practice management software for an affordable scheduling, billing and clinical information system.

"MediNotes and Per-Se share a common goal to bring intelligent solutions to physicians," said Donald G. Schoen, CEO and president, MediNotes Corporation. "Continuing to pair our EMR with Per-Se's Lytec and Medisoft systems presents a robust solution that is accessible to small physician groups."

"The size of your practice should not limit your access to affordable and intelligent practice management solutions," said Steve Kilguss, senior vice president and general manager of Per-Se's practice management solutions, Physician Solutions Division. "By working with an EMR leader, we're bringing more functionality to more than 100,000 physicians who currently use our systems. And we'll continue to explore opportunities to further simplify the administrative complexities of healthcare business."

Physicians who use this total solution also get the added benefit of e-Prescribing transaction processing services. This access helps facilitate pharmacy and prescriber communications for electronic prescription drug orders and refill authorizations.

Be the First To Comment

(Please read our comments policy first.)

From:
Show my identity with comment
Your Comment:

Leave this field empty